Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory.

Similar documents
1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia

Forensic Toxicology Scope of Testing and Detection Limits

Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine

Validation of a Benzodiazepine and Z-Drug Method Using an Agilent 6430 LC/MS/MS

Test Definition: PCDSO Pain Clinic Drug Screen, Urine

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions

LCMS-8050 Drugs of Abuse: 113 Analytes with Polarity Switching

Toxicological Investigation of Drug Impaired Driving Toxicology Laboratory Survey

Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K.

Pinellas County Forensic Laboratory. Annual Report 2006

ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS

Cross-reactivity reactivity in EMIT

Laboratory Service Report

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY

Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens

The Drug Testing Process. Employer or Practice

Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up

INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY

LC Application Note. Dangerous driver?

Jen L. Schroeder, B.S.

European Guidelines for Workplace Drug Testing in UrineandOral fluid

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J.

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

INTERPATH LABORATORY, INC. TEST UPDATES

Schedule of Accreditation

Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082

Applications of High Resolution Mass Spectrometry in Forensic Toxicology. Patrick Kyle, PhD.

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS

Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples

Physician s Reference for Urine and Blood Drug Testing and Interpretation

E XCEL LENCE JUST GOT BETTER UCT FORENSICS CLEAN SCREEN XCEL SPE COLUMNS

Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies

Pain Medication Management Program Monitors Patient Compliance

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population

European Guidelines for Workplace Drug Testing in Blood and Blood Spots

ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016)

Fully Automated Online Sample Preparation and LC-MS/MS Analysis of Drugs of Abuse in Oral Fluids

Pain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

Urine Drug Testing Methods 3-5

What Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital

CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva)

VIRGINIA DEPARTMENT OF HEALTH OFFICE OF THE CHIEF MEDICAL EXAMINER

Drug Profiles of Apprehended Drivers in Victoria

A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

Pain Medication Management Program Supports Patient Outcomes and Adherence

LABORATORY TECHNICAL SPECIFICATIONS MANUAL

An Introduction to Forensic Toxicology

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

Urine Opioid Dependency Panel (UODP) 1

Rapid LC/TOF MS for Analytical Screening of Drugs in the Clinical Research Lab

Welcome - SAMHSA s Role. Welcome SAMHSA Key Messages 4. Welcome SAMHSA s Direction

POINT OF CARE TESTING

LABORATORY TECHNICAL SPECIFICATIONS MANUAL

DrugSmartCup & DrugSmartDip Accuracy Report as produced by Ameditech, Inc.

Jonathan Rochon, Pier-Luc Plante, Serge Auger, Réal Paquin, Jacques Corbeil, Pierre Picard

The Drug Evaluation and Classification Program

WELCOME! 12/13/2018. Today s Topic: Urine Drug Screens in OUD Treatment UW PACC

Urine Drug Screening: The Essentials of Interpretation

Procedure for Toxicology Analysis Version 4 Toxicology Unit Effective Date: 05/10/2013. Toxicology Analysis

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Pharmacokinetics and Disposition of UDM Comparison of Various Sources for Drug Testing: Urine, Blood, Hair, Saliva. Edward J. Cone, Ph.D.

Learning Objectives. Drug Testing 10/17/2012. Utilization of the urine drug screen: The good, the bad, and the ugly

Contract No. 952-M1 Collection Service Requirements Texas Department of Criminal Justice (TDCJ)

nextgen precision Test Report

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities

LABORATORY TECHNICAL SPECIFICATIONS MANUAL

Fastect II Drug Screen Dipstick Test Training and Certification Program

Urine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016

Quantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate Mass AxION 2 TOF Mass Spectrometer

National Drug Early Warning System (NDEWS) Sentinel Community Site (SCS) Drug Use Patterns and Trends: SCE Narrative

EDUCATIONAL COMMENTARY rd TEST EVENT Chemistry Urine Drug Testing

T2007 Seattle, Washington

Community Drug Early Warning System (CDEWS-3): Washington, DC - Site 3 of 4

Drug Adherence Assessment Report

PARTICIPANT GENERAL INFORMATION

Drugs of Abuse I Serum

Substance Abuse Testing Electronic Result Reporting Layout Specifications. Version 3.2 January 2004

DOF. Scheme Description. Drugs in Oral Fluid Scheme

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain

Comparison of Different Whole Blood Sample Pretreatment Methods for Targeted Analysis of Basic Drugs

[ APPLICATION NOTE ] APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS

C O P E. Milwaukee County Opioid-Related Overdose Report MILWAUKEE COMMUNITY OPIOID PREVENTION EFFORT

Caring for ME Webinar: Urine Drug Screening Speaker: Dr. Jonathan Fellers Tuesday, November 20, PM

Urine Drug Analysis Test No Summary Report

Bree Collaborative AMDG Opioid Prescribing Guidelines Workgroup. Opioid Prescribing Metrics - DRAFT

Prepared by Date Adopted Supersedes Procedure # Review Date Revision Date Signature. Distributed to # of Copies Distributed to # of Copies

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017

Cozart DDS Drug Detection System On-site Saliva Drug Testing

Toxicology 101. Arizona Problem Solving Courts April 25, 2016

METHAMPHETAMINE & AMPHETAMINE

Controlled Substance Monitoring in the Age of the Opioid Epidemic

DrugConfirm Advanced Instant Urine Drug Test Cups Training Guide.

Oxymorphone Distribution in Biological Matrices: A Collection of Case Studies

Procedure for Toxicology Analysis Version 7 Toxicology Unit Effective Date: 03/14/2014 Issued by Drug Chemistry Forensic Scientist Manager

The Prevalence of Marijuana in Suspected Impaired Driving Cases in Washington State

Intercept i2he Opiate Oral Fluid Assay

Determination of 78 Banned or Controlled Racing Industry Drugs in Horse Urine Using SPE and LC-MS/MS

2015 Annual Physician Notice

Transcription:

Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory Lyndsey.Knoy@wsp.wa.gov

Forensic Toxicology is an interdisciplinary science that analyzes blood, fluid and/or tissues for the presence of alcohol, drugs, or poisons and applies the results of that analysis to answer the question: Did drugs and/or alcohol contribute to a person s impairment and/or their death?

WSP FLSB Crime Lab Toxicology Lab Breath Test Section DRE Program

Seattle laboratory services WA, AK, OR State Toxicologist Fiona Couper Lab Manager Brianna Peterson QA Manager Amanda Black Technical Lead- Brianne O Reilly 2 Supervisors Brian Capron, Brittany Thomas 14 Toxicologists Support staff

State Toxicology Lab Services Medical Examiners and Coroners -Death Investigations Law Enforcement Agencies -DUI and DRE Drug Facilitated Sexual Assaults Liquor and Cannabis Control Board Labor and Industry

Death Investigations Overdoses Suicides Poisonings Traffic Fatalities Homicides Undetermined

Police Investigations DUI/DRE Drug Investigations Drug Endangered Children Liquor and Cannabis Board Drug Facilitated Sexual Assaults

2017 15,947 cases! We receive ~1300 cases/month! 675 from AK, 226 from OR DUI/DRE: 10,272 Top Drugs of 2017: Ethanol THC/COOH-THC Methamphetamine/amphetamine Morphine LK: 1,496 cases! 2016-14,617 cases Court Testimony for 2017 1,529 hours for 308 appearances LK: 139 hours for 26 cases

Sample receipt and log-in (Bob Smith, Former PEC) Data Analysis (Andrew Gingras) Create Report Lab analysis (Katie Harris) Expert Testimony Agency/Prosecutor

1. Sample receipt and accession 2. Alcohol analysis 3. Drug screen analysis 4. Confirmation analysis 5. Specialty drug analysis 6. Prepare report 7. Review by supervisors and manager

US Postal Service Courier (UPS / FedEx) Hand delivered Campus mail

Logged in as they arrive by a PEC Photos are taken of mail packaging and evidence seals Each sample checked for name, agency case#, volume and tampering Each case receives a Unique identifier number (eg. ST-18-00001) Maintains chain of custody

Each case entered in LIMS database ST# is used to track samples in the laboratory Currently about 80 cases are received daily

1. Sample receipt and accession 2. Alcohol analysis 3. Drug screen analysis 4. Confirmation analysis 5. Specialty drug analysis 6. Prepare report 7. Review by supervisors and manager

Forensic collection of sample Gray top tube Preservative (NaF) & anticoagulant (C 2 K 2 O 4 ) FDA Regulated Certificates from the manufacturer Experts can testify to hearsay Samples are not clotted Vacuum Expiration Date: refers to vacuum

All samples are tested for alcohol (ethanol) Head-Space Gas Chromatography (HS/GC) Run in duplicate Two aliquots Two instruments Different columns Different temperature programs Calibrators for each run Control and negative every ten samples

Alcohol is a volatile When heated, volatiles enter the vapor phase Vapor is injected onto a long-thin column Compounds on column separated by physicalchemical properties (size, shape, volatility, charge) Ethanol has a unique retention time Distinguishes between ethanol and other volatiles Isopropanol from swabs Acetone from diabetes

Calibration curve for both instruments (r 2 0.99) Controls must be within 10% of the target Blank cannot contain any peaks Results from each case must agree within 10% of the mean from both results Check for other volatiles in sample

1. Sample receipt and accession 2. Alcohol analysis 3. Drug screen analysis 4. Confirmation analysis 5. Specialty drug analysis 6. Prepare report 7. Review by supervisors and manager

Drug Screening Enzyme Multiplied Immunoassay Technique (EMIT) Chemical lock and key test Qualitative Class, not compound specific Rule in/rule out for major CNS drug categories Each drug has cut-off level: Blood cut off < urine cut-off Drugs may be present below cut-off

6 classes screened Cocaine metabolite Opiates Benzodiazepines Barbiturates Cannabinoids Amphetamines 4 classes screened for urine (amphetamines and cannabinoids omitted)

Zolpidem Diphenhydramine Dextromethorphan Certain benzodiazepines: Lorazepam, Clonazepam Fentanyl Acidic/Neutral drugs: Anti-seizures, Soma Most synthetics: bath salts, synthetic cannabinoids SSRI drugs: Citalopram, Fluoxetine, Paroxetine, Venlafaxine, Sertraline Most antipsychotics

Blood specimens require extraction procedure Calibrators, controls and blank extracted with each set Positive results must be confirmed

Alkaline (basic) drug screen Samples are extracted through a series of steps Calibrators, controls and blanks extracted Purifies and concentrates drugs

Analysis by Gas Chromatography/Mass Spectrometry (GC/MS and GC/NPD) Separates drugs based on unique chemical properties Provides unique chemical fingerprint for drugs

MS NPD

BDS Drug Screen Not absolutely comprehensive Also has a cut-off, more sensitive than immunoassay -distinguish specific member of drug class Drugs may be present below cut-off Drugs not confirmed reported as not detected

1. Sample receipt and accession 2. Alcohol analysis 3. Drug Screen analysis 4. Confirmation analysis 5. Specialty drug analysis 6. Prepare report 7. Review by supervisors and manager

1.Extraction of Sample 2.Analysis of sample using GC/MS; GC/FID; LCMS; LCMSMS

1. Sample receipt and accession 2. Alcohol analysis 3. Drug screen analysis 4. Confirmation analysis 5. Specialty drug analysis 6. Prepare report 7. Review by supervisors and manager

Specialty Tests for Drugs Some drugs require special extractions for detection THC Cocaine metabolites Some Opiates (morphine, hydromorphone) Some Benzodiazepines (clonazepam) Confirmation by GC/MS, LC/MS, or LC/MS/MS Method of extraction and analysis allows greater sensitivity

Analysts must be certified for analysis of these drugs Typically, solid phase extraction (SPE) Blank, calibrators, controls extracted with each set of cases

THC 1 ng/ml Zolpidem 0.01 mg/l Cocaine, BZE, cocaethylene 0.01 mg/l Methadone 0.01 mg/l PCP 0.01 mg/l Amines- 0.01 mg/l includes amphetamine, methamphetamine, MDA, MDMA Barbiturates- 0.5 mg/l includes amobarbital, phenobarbital, pentobarbital, secobarbital, butalbital Opiates: morphine, oxymorphone, oxycodone, codeine, hydrocodone= 0.01 mg/l; hydromorphone, 6-AM= 2 ng/ml Benzodiazepines- 0.01 mg/l for diazepam, temazepam, nordiazepam, zopiclone, alprazolam, clonazepam, lorazepam, oxazepam, midazolam, chlordiazepoxide, triazolam, flurazepam, flunitrazepam; 0.02 mg/l for quetiapine

Currently, WSTL does not have testing protocols for designer drugs Cases sent to two contract laboratories: NMS Labs (Pennsylvania) AIT Laboratories (Indiana) Cases will be sent to contract lab if indicated on request form and no other drug(s) is detected

Refrigerated while not testing Samples removed from fridge only while preparing for tests Evidence maintained in locked personal fridges or in evidence vault

1. Sample receipt and accession 2. Alcohol analysis 3. Drug Screen analysis 4. Confirmation analysis 5. Specialty drug analysis 6. Preparation of report 7. Review by supervisors and manager

Review all data files from sequence Blanks are blank Negatives have ISTD Calibration curve is acceptable (R 2 0.99) Controls are within range Identify/quantifies drug(s) present All data is reviewed by other analysts and/or supervisors

Report prepared after all testing is completed for each specific case All batches of data peer and supervisor reviewed prior to release All compounds present above level of quantitation are reported 2 tests- screened and confirmed Retention time-matched and fingerprint ID Quantitative vs. Qualitative Quantitative gives value of drug present in blood (0.04 mg/l or 3 ng/ml) Qualitative Positive without level Parent drug and metabolites can be reported Metabolites may or may not be active

Analyst, dates, and methodology Any test not performed by the primary analyst is indicated below the specific test result

TWO pages! or more Agency owns report

Quality Assurance Record keeping, compliance with SOPs, corrective actions Quality Control Proficiency testing (CAP and WSLH), accuracy of test QA/QC system assures results are accurate, precise, and meaningful Calibration Lab accredited by ASCLD/LAB Tox Lab accredited by ABFT and ASCLD/LAB

Testimony! Entire state- Breath and blood Alaska- Blood Oregon- Blood Instrument maintenance Continuing Education workshops, seminars, conferences Educating the public high schools, attorney conferences, continuing ed for police agencies, legislature

(206) 262-6100 toxlab@wsp.wa.gov Lyndsey.Knoy@wsp.wa.gov